Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Transmedics Group Inc (NASDAQ: TMDX) closed at $80.93 in the last session, up 0.56% from day before closing price of $80.48. In other words, the price has increased by $0.56 from its previous closing price. On the day, 1.81 million shares were traded. TMDX stock price reached its highest trading level at $81.31 during the session, while it also had its lowest trading level at $76.2101.
Ratios:
We take a closer look at TMDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.33 and its Current Ratio is at 8.20. In the meantime, Its Debt-to-Equity ratio is 2.47 whereas as Long-Term Debt/Eq ratio is at 2.46.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on October 29, 2024, Reiterated its Outperform rating but revised its target price to $125 from $200 previously.
On October 29, 2024, Needham reiterated its Buy rating and also upped its target price recommendation from $208 to $109.
On September 24, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $200.Robert W. Baird initiated its Outperform rating on September 24, 2024, with a $200 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 11 ’24 when Khayal Tamer I sold 1,458 shares for $90.04 per share. The transaction valued at 131,278 led to the insider holds 20,843 shares of the business.
Basile Edward M sold 6,750 shares of TMDX for $563,994 on Nov 05 ’24. The Director now owns 732 shares after completing the transaction at $83.55 per share. On Nov 01 ’24, another insider, Khayal Tamer I, who serves as the Chief Commercial Officer of the company, sold 1,083 shares for $82.64 each. As a result, the insider received 89,499 and left with 20,843 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMDX now has a Market Capitalization of 2716132096 and an Enterprise Value of 2889082880. As of this moment, Transmedics’s Price-to-Earnings (P/E) ratio for their current fiscal year is 86.70, and their Forward P/E ratio for the next fiscal year is 50.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.17 while its Price-to-Book (P/B) ratio in mrq is 12.94. Its current Enterprise Value per Revenue stands at 7.203 whereas that against EBITDA is 56.496.
Stock Price History:
The Beta on a monthly basis for TMDX is 2.07, which has changed by 0.1854471 over the last 52 weeks, in comparison to a change of 0.2936039 over the same period for the S&P500. Over the past 52 weeks, TMDX has reached a high of $177.37, while it has fallen to a 52-week low of $63.85. The 50-Day Moving Average of the stock is -34.98%, while the 200-Day Moving Average is calculated to be -33.85%.
Shares Statistics:
According to the various share statistics, TMDX traded on average about 1.46M shares per day over the past 3-months and 1552100 shares per day over the past 10 days. A total of 32.67M shares are outstanding, with a floating share count of 32.44M. Insiders hold about 3.35% of the company’s shares, while institutions hold 109.95% stake in the company. Shares short for TMDX as of 1730332800 were 8426990 with a Short Ratio of 5.77, compared to 1727654400 on 6016782. Therefore, it implies a Short% of Shares Outstanding of 8426990 and a Short% of Float of 30.54.
